DE69128465T2 - Heparinneutralisierung durch blutplättchenfaktor - Google Patents

Heparinneutralisierung durch blutplättchenfaktor

Info

Publication number
DE69128465T2
DE69128465T2 DE69128465T DE69128465T DE69128465T2 DE 69128465 T2 DE69128465 T2 DE 69128465T2 DE 69128465 T DE69128465 T DE 69128465T DE 69128465 T DE69128465 T DE 69128465T DE 69128465 T2 DE69128465 T2 DE 69128465T2
Authority
DE
Germany
Prior art keywords
blood plate
heparin
heparin neutralization
plate factor
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69128465T
Other languages
English (en)
Other versions
DE69128465D1 (de
Inventor
Jacquelynn Cook
Stefan Niewarowski
Theodore E Maione
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repligen Corp
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of DE69128465D1 publication Critical patent/DE69128465D1/de
Application granted granted Critical
Publication of DE69128465T2 publication Critical patent/DE69128465T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69128465T 1990-02-16 1991-02-14 Heparinneutralisierung durch blutplättchenfaktor Expired - Fee Related DE69128465T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48087390A 1990-02-16 1990-02-16
PCT/US1991/001051 WO1991012017A1 (en) 1990-02-16 1991-02-14 Heparin neutralization with platelet factor 4

Publications (2)

Publication Number Publication Date
DE69128465D1 DE69128465D1 (de) 1998-01-29
DE69128465T2 true DE69128465T2 (de) 1998-04-16

Family

ID=23909691

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69128465T Expired - Fee Related DE69128465T2 (de) 1990-02-16 1991-02-14 Heparinneutralisierung durch blutplättchenfaktor

Country Status (9)

Country Link
EP (1) EP0515550B1 (de)
JP (1) JPH05505602A (de)
AT (1) ATE161183T1 (de)
CA (1) CA2075957A1 (de)
DE (1) DE69128465T2 (de)
DK (1) DK0515550T3 (de)
ES (1) ES2112271T3 (de)
GR (1) GR3025878T3 (de)
WO (1) WO1991012017A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585095A (en) * 1993-09-14 1996-12-17 Regents Of The University Of Minnesota Method to enhance thrombomodulin APC generation using cationic proteins
WO1998038214A1 (en) * 1997-02-28 1998-09-03 The Texas A & M University System Heparan sulfate/heparin interacting protein compositions and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses

Also Published As

Publication number Publication date
DE69128465D1 (de) 1998-01-29
ATE161183T1 (de) 1998-01-15
ES2112271T3 (es) 1998-04-01
WO1991012017A1 (en) 1991-08-22
CA2075957A1 (en) 1991-08-17
EP0515550B1 (de) 1997-12-17
JPH05505602A (ja) 1993-08-19
EP0515550A4 (en) 1993-06-30
GR3025878T3 (en) 1998-04-30
DK0515550T3 (da) 1998-02-02
EP0515550A1 (de) 1992-12-02

Similar Documents

Publication Publication Date Title
DK641889D0 (da) Anvendelse af en blodpladeaktiveringsfaktorantagonist i kombination med monoklonale eller polyklonale antistoffer i et farmaceutisk praeparat til behandling af endotoksisk chok hos pattedyr
ATE249518T1 (de) Humanisierter antikörper gegen cd18
DK108491A (da) Nucleosider og nucleosidanaloge samt farmaceutiske praeparater indeholdende disse forbindelser
IT8223892A0 (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle.
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
IT8048137A0 (it) Preparato di fruttosio-1,6-difosfato ad azione protettiva della membrana degli eritrociti in pazienti sottoposti a circolazione extracorporea
ES2055314T3 (es) Tratamiento de disfuncion leucocitaria con gm-csf.
ATA192290A (de) Schubladenführung mit auszugschiene
DE69128465T2 (de) Heparinneutralisierung durch blutplättchenfaktor
DK0535129T3 (da) Et antikoagulerende præparat
ES2038721T3 (es) Procedimiento para la purificacion de la proteina pp4 del tejido placentario.
DE59002185D1 (de) Kombinationspraeparat mit antithrombotischer wirkung.
FR2534477B1 (fr) Articles medicaux
ES2013695B3 (es) Compuestos de coordinacion de platino
DK225689D0 (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
BR8102386A (pt) Aperfeicoamento em processo de cura de borracha insaturada
FR2603784B1 (fr) Meuble de relaxation multi-positions
FR2539155B1 (fr) Traitement de copeaux de bois
IT8000220V0 (it) Anta per mobili
KR890700352A (ko) 히드라진 설페이트를 사용하여 암환자의 생존을 연장시키는 방법
IT8184128A0 (it) Dispositivo per bloccare in apertura qualsiasi tipo di cerniere per anta.
MX9201665A (es) Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.
LV5675A3 (lv) Panemiens cilveka leikocitaro interferonu iegusanai
ES263438Y (es) "disposicion perfeccionada en la constitucion de puertas para muebles de cocina o similares".
BR8007912A (pt) Mecanismo curativo segundo principio de acao bioenergetica

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee